Valuation: DexCom, Inc.

Market Cap 31.85B 28.45B 26.46B 24.07B 45.45B 3,083B 45.65B 319B 125B 1,572B 120B 117B 5,044B P/E 2026 *
33.9x
P/E 2027 * 28.6x
Enterprise Value 31.09B 27.77B 25.83B 23.5B 44.36B 3,009B 44.55B 311B 122B 1,534B 117B 114B 4,923B EV / Sales 2026 *
5.94x
EV / Sales 2027 * 5.31x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-0.36%
1 week-1.46%
Current month-2.53%
1 month+0.27%
3 months+15.19%
6 months+28.06%
Current year+26.73%
1 week 82.86
Extreme 82.86
87.12
1 month 82.29
Extreme 82.29
90.38
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap. Importance
28/9/26 Sell

Head of Human Resources

-2,565 0.0007%
15/9/26 Sell

Compliance Officer

-1,700 0.0005%
15/9/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-1.46%+23.55%+1.23% 31.85B
+1.13%+2.15%-25.29%+2.94% 170B
+0.83%+2.43%-8.31%+17.77% 112B
+0.13%+0.69%-25.09%+3.95% 106B
+2.34%+1.21%-47.49%-10.79% 73.6B
+0.78%+4.79%+3.10%+73.94% 61.32B
+0.12%+2.73%+13.09%+67.70% 52.89B
+0.55%+3.93%-2.82%-30.87% 49.78B
+0.95%-0.08%-17.61%+17.13% 40.43B
+1.45%+1.83% - - 31.36B
Average +0.81%+1.39%-9.65%+15.89% 73.01B
Weighted average by Cap. +0.89%+1.57%-15.20%+13.49%

Financials

2026 *2027 *
Net sales 5.23B 4.67B 4.35B 3.95B 7.46B 506B 7.49B 52.3B 20.49B 258B 19.64B 19.21B 828B 5.8B 5.18B 4.82B 4.38B 8.28B 561B 8.31B 57.99B 22.72B 286B 21.78B 21.3B 918B
Net income 974M 870M 810M 736M 1.39B 94.3B 1.4B 9.74B 3.82B 48.08B 3.66B 3.58B 154B 1.15B 1.03B 955M 868M 1.64B 111B 1.65B 11.49B 4.5B 56.69B 4.31B 4.22B 182B
Net Debt -761M -680M -632M -575M -1.09B -73.66B -1.09B -7.61B -2.98B -37.56B -2.86B -2.8B -121B -1.06B -948M -882M -802M -1.51B -103B -1.52B -10.61B -4.16B -52.38B -3.99B -3.9B -168B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
10/10/26 US$84.11 -0.36% 3,112,206
08/10/26 US$84.41 +0.13% 3,607,110
07/10/26 US$84.30 +1.09% 2,863,835
06/10/26 US$83.39 -4.04% 3,574,805
05/10/26 US$86.90 +1.80% 3,079,140
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
84.41USD
Average target price
96.23USD
Spread / Average Target
+14.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock